As shown in Fig. 4c, a lower level of HPN was associated with worse prognosis in HCC patients, evidenced by a prominently decreased (61.6%) OS in the HPN low-expressing group (290 vs 756 days, P = 0.0057). Here, HPN is linked to hepatocellular carcinoma.